Neuronal Cholesterol Esterification by ACAT1 in Alzheimer's Disease

被引：15
|
作者：
Chang, Ta-Yuan [1 ]
Chang, Catherine C. Y. [1 ]
Bryleva, Elena [1 ]
Rogers, Maximillian A. [1 ]
Murphy, Stephanie R. [1 ]
机构：
[1] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA
来源：
IUBMB LIFE | 2010年 / 62卷 / 04期
关键词：
cholesterol metabolism; ACAT1; oxysterols; Alzheimer's disease; HUMAN ATHEROSCLEROTIC LESIONS; HAMSTER OVARY CELLS; MAMMALIAN ACYL-COA; A-BETA; MOLECULAR-CLONING; PRECURSOR PROTEIN; NUCLEAR RECEPTORS; LIPID-METABOLISM; MOUSE-BRAIN; HUMAN LIVER;
D O I：
10.1002/iub.305
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cholesterol has been implicated in various neurodegenerative diseases. Here we review the connection between cholesterol and Alzheimer's disease (AD), focusing on a recent study that links neuronal cholesterol esterification with biosynthesis of 24(S)hydroxycholesterol and the fate of human amyloid precursor protein in a mouse model of AD. We also briefly evaluate the potential of ACAT1 as a drug target for AD. (C) 2010 IUBMB IUBMB Life, 62(4): 261-267, 2010
引用
收藏
页码：261 / 267
页数：7
相关论文
共 50 条
  • [1] Role of ACAT1 in Atherosclerosis and Alzheimer's Disease
    Link, Tina
    Reddy, Megan
    Agasthi, Sarayu
    Handa, Samir
    Manikkoth, Shria
    Ray, Allison
    FASEB JOURNAL, 2022, 36
  • [2] ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
    Shibuya, Yohei
    Chang, Catherine C. Y.
    Chang, Ta-Yuan
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (18) : 2451 - 2467
  • [3] ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease
    Sarahi Alavez-Rubio, Jessica
    Juarez-Cedillo, Teresa
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (08) : 699 - 709
  • [4] ACAT1 is not associated with Alzheimer's disease in two independent family-based samples
    Bertram, L
    Hsiao, M
    Mullin, K
    Parkinson, M
    Menon, R
    Moscarillo, TJ
    Blacker, D
    Tanzi, RE
    MOLECULAR PSYCHIATRY, 2005, 10 (06) : 522 - 524
  • [5] ACAT1 is not associated with Alzheimer's disease in two independent family-based samples
    L Bertram
    M Hsiao
    K Mullin
    M Parkinson
    R Menon
    T J Moscarillo
    D Blacker
    R E Tanzi
    Molecular Psychiatry, 2005, 10 : 522 - 524
  • [6] Acat1 Knockdown Gene Therapy Decreases Amyloid-β in a Mouse Model of Alzheimer's Disease
    Murphy, Stephanie R.
    Chang, Catherine C. Y.
    Dogbevia, Godwin
    Bryleva, Elena Y.
    Bowen, Zachary
    Hasan, Mazahir T.
    Chang, Ta-Yuan
    MOLECULAR THERAPY, 2013, 21 (08) : 1497 - 1506
  • [7] ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages
    Dove, Dwayne E.
    Su, Yan Ru
    Swift, Larry L.
    Linton, MacRae F.
    Fazio, Sergio
    ATHEROSCLEROSIS, 2006, 186 (02) : 267 - 274
  • [8] PET Imaging of Cholesterol Metabolism by a Cholesterol Analogue Radiotracer and ACAT1 Inhibitor Radioligand
    Brooks, Allen
    Hill, James
    Verhoog, Stefan
    Winton, Wade
    Shao, Xia
    Viglianti, Benjamin
    Scott, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Cholesterol, neuronal activity and Alzheimer's disease
    Pierrot, Nathalie
    Octave, Jean-Noel
    M S-MEDECINE SCIENCES, 2014, 30 (03): : 244 - 246
  • [10] Role of acyl-coenzyme A: cholesterol transferase 1 (ACAT1) in retinal neovascularization
    Syed A. H. Zaidi
    Tahira Lemtalsi
    Zhimin Xu
    Isabella Santana
    Porsche Sandow
    Leila Labazi
    Robert W. Caldwell
    Ruth B. Caldwell
    Modesto A. Rojas
    Journal of Neuroinflammation, 20
12345